Roble Belko & Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$124K	Hold	279	–	–	0.02%	128
2025 Q1	$135K	Hold	279	–	–	0.02%	121
2024 Q4	$112K	Sell	279 -63	-18%	-$25.3K	0.02%	132
2024 Q3	$159K	Hold	342	–	–	0.03%	111
2024 Q2	$160K	Hold	342	–	–	0.03%	112
2024 Q1	$143K	Hold	342	–	–	0.02%	117
2023 Q4	$139K	Hold	342	–	–	0.03%	107
2023 Q3	$119K	Hold	342	–	–	0.02%	112
2023 Q2	$120K	Hold	342	–	–	0.02%	109
2023 Q1	$108K	Hold	342	–	–	0.02%	120
2022 Q4	$99K	Hold	342	–	–	0.02%	126
2022 Q3	$99K	Hold	342	–	–	0.02%	122
2022 Q2	$96K	Hold	342	–	–	0.02%	128
2022 Q1	$89K	Sell	342 -12	-3%	-$3.12K	0.02%	138
2021 Q4	$78K	Hold	354	–	–	0.01%	136
2021 Q3	$64K	Hold	354	–	–	0.01%	134
2021 Q2	$71K	Hold	354	–	–	0.02%	142
2021 Q1	$76K	Hold	354	–	–	0.02%	129
2020 Q4	$84K	Hold	354	–	–	0.02%	118
2020 Q3	$96K	Buy	354 +12	+4%	+$3.25K	0.03%	110
2020 Q2	$99K	Hold	342	–	–	0.03%	116
2020 Q1	$81K	Hold	342	–	–	0.03%	123
2019 Q4	$75K	Hold	342	–	–	0.02%	138
2019 Q3	$58K	Hold	342	–	–	0.02%	140
2019 Q2	$63K	Hold	342	–	–	0.02%	138
2019 Q1	$63K	Hold	342	–	–	0.02%	110
2018 Q4	$57K	Hold	342	–	–	0.02%	109
2018 Q3	$66K	Hold	342	–	–	0.02%	98
2018 Q2	$58K	Hold	342	–	–	0.02%	105
2018 Q1	$56K	Buy	342 +47	+16%	+$7.7K	0.02%	114
2017 Q4	$44K	Buy	+295	New	+$44K	0.02%	119
2017 Q2	–	Sell	-23	Closed	-$3K	–	351
2017 Q1	$3K	Hold	23	–	–	﹤0.01%	296
2016 Q4	$2K	Buy	+23	New	+$2K	﹤0.01%	330